Benchmark Co. Maintains Quipt Home Medical(QIPT.US) With Buy Rating, Cuts Target Price to $6
Benchmark Co. Remains a Buy on Quipt Home Medical (QIPT)
Quipt Home Medical Price Target Lowered to $6 From $7 at Benchmark
Earnings Call Summary | Quipt Home Medical(QIPT.US) Q4 2024 Earnings Conference
Quipt Home Medical Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results.
Quipt Home Medical Corp. (QIPT) Reports Q4 Loss, Misses Revenue Estimates
Quipt Home Medical Posts Wider Fourth-quarter Net Loss, Higher Revenue
Quipt Home Medical | 10-K: FY2024 Annual Report
Quipt Home Medical | 8-K: QUIPT HOME MEDICAL REPORTS FOURTH QUARTER AND FISCAL YEAR 2024 FINANCIAL RESULTS POSTS STRONG ADJUSTED EBITDA MARGIN 1 FOR FISCAL YEAR 2024 AND RETURNS TO POSITIVE SEQUENTIAL GROWTH IN FISCAL Q4 2024
Quipt Home Medical GAAP EPS of -$0.16 Misses by $0.05, Revenue of $245.9M Misses by $7.39M
Express News | Quipt Home Medical Q4 Revenue USD 61.3 Million
Express News | Quipt Home Medical Q4 Adjusted Ebitda USD 13.4 Million
Earnings Scheduled For December 16, 2024
Earnings Preview For Quipt Home Medical
Exploring Quipt Home Medical's Earnings Expectations
Express News | Forager Fund, L.p. Reports 9.7% Stake in Quipt Home Medical Corp as of Dec 11 - SEC Filing
Earnings Preview: QIPT to Report Financial Results Post-market on December 16
Quipt Home Medical Corp. to Announce Fiscal Fourth Quarter and Full Year 2024 Financial Results on December 16, 2024
Quipt Home Medical Price Target Lowered to C$7.50 From C$8.50 at Stifel
Stifel Maintains Quipt Home Medical(QIPT.US) With Buy Rating, Cuts Target Price to $5.35
No Data